The AMA and ACOG have collaborated to revise billing codes for maternity care service, which will better reflect modern obstetric practice.

Drug companies involved in price deals with President Trump have continued to raise prices on hundreds of medications.

Teplizumab is now approved for children as young as 1 year with stage 2 type 1 diabetes, following study results on safety and pharmacokinetics.

High-dose tirzepatide is associated with superior HbA1c reduction and weight loss compared with semaglutide in type 2 ...

Tirzepatide significantly improves health-related quality of life and physical functioning compared with dulaglutide in ...

BMI z-score reduction of at least 0.25 is associated with lower risks for type 2 diabetes and hypertension in children with MHO and MUO.

Phase 3 trial data show a synthetic semaglutide injection provides glycemic control comparable to Ozempic in patients with ...

Veligrotug yields rapid and substantial reductions in proptosis for adults with active thyroid eye disease, according to ...

Orforglipron significantly reduces body weight across all BMI categories in the ATTAIN-1 trial, with results presented at ...

Use of certain GLP-1 RAs is associated with a modestly increased risk for new-onset rheumatoid arthritis (RA).

Patients with hematologic malignancies have an increased risk for cardiovascular disease (CVD) compared with the general population.

Long-term excess weight exposure influences cardiovascular risk more than excess weight at a single point in time.